361 related articles for article (PubMed ID: 22923001)
21. Therapeutic Utility of Opioids for Restless Legs Syndrome.
Mackie SE; Winkelman JW
Drugs; 2017 Aug; 77(12):1337-1344. PubMed ID: 28616844
[TBL] [Abstract][Full Text] [Related]
22. Treatment of restless legs syndrome.
Comella CL
Neurotherapeutics; 2014 Jan; 11(1):177-87. PubMed ID: 24363103
[TBL] [Abstract][Full Text] [Related]
23. Pharmacologic and Nonpharmacologic Treatment of Restless Legs Syndrome.
Anguelova GV; Vlak MHM; Kurvers AGY; Rijsman RM
Sleep Med Clin; 2018 Jun; 13(2):219-230. PubMed ID: 29759272
[TBL] [Abstract][Full Text] [Related]
24. Medications for restless legs syndrome in pregnancy.
Djokanovic N; Garcia-Bournissen F; Koren G
J Obstet Gynaecol Can; 2008 Jun; 30(6):505-507. PubMed ID: 18611302
[TBL] [Abstract][Full Text] [Related]
25. Newer dopamine agonists in the treatment of restless legs syndrome.
Weimerskirch PR; Ernst ME
Ann Pharmacother; 2001 May; 35(5):627-30. PubMed ID: 11346069
[TBL] [Abstract][Full Text] [Related]
26. [Management of restless legs syndrome].
Haba-Rubio J; Krieger J
Presse Med; 2010 May; 39(5):571-8. PubMed ID: 20303704
[TBL] [Abstract][Full Text] [Related]
27. Latest guidelines and advances for treatment of restless legs syndrome.
Earley CJ
J Clin Psychiatry; 2014 Apr; 75(4):e08. PubMed ID: 24813409
[TBL] [Abstract][Full Text] [Related]
28. Opioids for restless legs syndrome.
de Oliveira CO; Carvalho LB; Carlos K; Conti C; de Oliveira MM; Prado LB; Prado GF
Cochrane Database Syst Rev; 2016 Jun; 2016(6):CD006941. PubMed ID: 27355187
[TBL] [Abstract][Full Text] [Related]
29. Restless legs syndrome: treatment with dopaminergic agents.
Comella CL
Neurology; 2002 Feb; 58(4 Suppl 1):S87-92. PubMed ID: 11909990
[TBL] [Abstract][Full Text] [Related]
30. Rotigotine transdermal delivery for the treatment of restless legs syndrome.
Sixel-Döring F; Trenkwalder C
Expert Opin Pharmacother; 2010 Mar; 11(4):649-56. PubMed ID: 20163275
[TBL] [Abstract][Full Text] [Related]
31. Decision-making, reward-seeking behaviors and dopamine agonist therapy in restless legs syndrome.
Bayard S; Langenier MC; Dauvilliers Y
Sleep; 2013 Oct; 36(10):1501-7. PubMed ID: 24082309
[TBL] [Abstract][Full Text] [Related]
32. Current treatment options for restless legs syndrome.
Wetter TC; Winkelmann J; Eisensehr I
Expert Opin Pharmacother; 2003 Oct; 4(10):1727-38. PubMed ID: 14521483
[TBL] [Abstract][Full Text] [Related]
33. Frequent difficulties in the treatment of restless legs syndrome - case report and literature review.
Narowska D; Bożek M; Krysiak K; Antczak J; Holka-Pokorska J; Jernajczyk W; Wichniak A
Psychiatr Pol; 2015; 49(5):921-30. PubMed ID: 26688843
[TBL] [Abstract][Full Text] [Related]
34. French consensus: Pharmacoresistant restless legs syndrome.
Chenini S; Arnulf I; Monaca CC; Ghorayeb I
Rev Neurol (Paris); 2018; 174(7-8):522-531. PubMed ID: 30075957
[TBL] [Abstract][Full Text] [Related]
35. Polysomnographic record and successful management of augmentation in restless legs syndrome/Willis-Ekbom disease.
Maestri M; Fulda S; Ferini-Strambi L; Zucconi M; Marelli S; Staedler C; Bassetti CL; Manconi M
Sleep Med; 2014 May; 15(5):570-5. PubMed ID: 24767724
[TBL] [Abstract][Full Text] [Related]
36. ADMET considerations for restless leg syndrome drug treatments.
de Biase S; Merlino G; Lorenzut S; Valente M; Gigli GL
Expert Opin Drug Metab Toxicol; 2012 Oct; 8(10):1247-61. PubMed ID: 22808933
[TBL] [Abstract][Full Text] [Related]
37. Restless legs syndrome: differential diagnosis and management with pramipexole.
Brindani F; Vitetta F; Gemignani F
Clin Interv Aging; 2009; 4():305-13. PubMed ID: 19750232
[TBL] [Abstract][Full Text] [Related]
38. Comparison of pregabalin with pramipexole for restless legs syndrome.
Allen RP; Chen C; Garcia-Borreguero D; Polo O; DuBrava S; Miceli J; Knapp L; Winkelman JW
N Engl J Med; 2014 Feb; 370(7):621-31. PubMed ID: 24521108
[TBL] [Abstract][Full Text] [Related]
39. Rotigotine transdermal patch: in restless legs syndrome.
Baldwin CM; Keating GM
CNS Drugs; 2008; 22(10):797-806. PubMed ID: 18788832
[TBL] [Abstract][Full Text] [Related]
40. Advancing synthetic therapies for the treatment of restless legs syndrome.
de Biase S; Pellitteri G; Gigli GL; Valente M
Expert Opin Pharmacother; 2019 Nov; 20(16):1971-1980. PubMed ID: 31424287
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
